New players in the preventive treatment of migraine.

BMC Med · 2015 · PMC4641418 · PMID 26555040

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

just missed significanceP = 0.054so close (0.05 < p ≤ 0.1)

Importantly, the primary endpoint of change in migraine days per month just missed significance in the intention-to-treat group ( P = 0.054) and was not significantly different in per protocol analysis ( P = 0.06) in the comparison between groups (tSNS and sham-treated).

also in 165 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.